A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn’t stopped contenders such as Roche’s emicizumab.
When discussing the nation’s ability to stomach orphan drug costs, an analyst has called the price tag “the straw that breaks the camel’s back.”
Teva Pharmaceutical Industries’ Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
Ads promoting Merck’s and Bristol-Myers Squibb’s immunotherapies could signal the beginning of a new era for DTC.
Last week President Trump told drugmakers that ‘the pricing has been astronomical.’
How can marketers incorporate patient feedback into their marketing strategies without expensive and time-consuming studies?
A new survey found that 34% of healthcare and pharma marketers say that the election of President Trump will not affect their marketing budgets.
Here are six global campaigns that make the case for persuasion.
She says her experience in consumer brands helps her push healthcare clients to be more creative.
The merger of Quintiles and IMS Health closed in October.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to: